These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 1712713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
    Knauf H, Mutschler E.
    Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T, Krämer B, Müller GA.
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
    Kramer WG.
    Cardiology; 1994; 84 Suppl 2():108-14. PubMed ID: 7954532
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of torasemide and its metabolites in end-stage renal disease.
    Krämer BK, Schwab A, Braun N, Strutz F, Müller GA, Risler T.
    Eur J Clin Pharmacol; 1994; 47(2):157-9. PubMed ID: 7859803
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P, La Villa G, Marra F, Carloni V, Melani L, Foschi M, Cotrozzi G, Quartini M, Chibbaro G, Tommasi AC, Bernareggi A, Simoni A, Buzzelli G, Laffi G.
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [Abstract] [Full Text] [Related]

  • 8. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA, Buckley MM.
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Dunn CJ, Fitton A, Brogden RN.
    Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and metabolism of torasemide in man.
    Neugebauer G, Besenfelder E, von Möllendorff E.
    Arzneimittelforschung; 1988 Jan; 38(1A):164-6. PubMed ID: 3370063
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.
    Spahn H, Knauf H, Mutschler E.
    Eur J Clin Pharmacol; 1990 Jan; 39(4):345-8. PubMed ID: 2076715
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H, Ohtaki Y.
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Failure of the loop diuretic torasemide to improve renal function of hypoxemic vasomotor nephropathy in the newborn rabbit.
    Dubourg L, Drukker A, Guignard JP.
    Pediatr Res; 2000 Apr; 47(4 Pt 1):504-8. PubMed ID: 10759158
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.